| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $999.6M | +16.0% |
| Cost of Revenue | $376.9M | +1.4% |
| Gross Profit | $622.6M | +27.0% |
| R&D Expense | $218.8M | +13.2% |
| SG&A Expense | $103.7M | +8.4% |
| Operating Income | $117.7M | +1199.5% |
| Interest Expense | $55.5M | +14.5% |
| Pre-tax Income | $75.0M | +297.0% |
| Income Tax | $19.3M |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $404.0M | +58.9% |
| Accounts Receivable | $104.9M | +8.3% |
| Current Assets | $557.4M | +45.6% |
| Total Assets | $3.16B | +2.4% |
| Current Liabilities | $117.1M | -10.7% |
| Long-term Debt | $875.0M | -5.4% |
| Total Liabilities | $1.13B | -5.4% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $242.8M | +61.2% |
| Capital Expenditures | $1.7M | -49.7% |
| Investing Cash Flow | -$46.1M | +61.3% |
| Financing Cash Flow | -$47.0M | -1661.1% |
| Free Cash Flow | $241.1M | +63.7% |
| +261.7% |
| Net Income | $55.7M | +313.1% |
| EPS (Basic) | $0.65 | +309.7% |
| EPS (Diluted) | $0.64 | +306.5% |
| Stockholders' Equity |
| $2.04B |
| +7.4% |